These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

455 related items for PubMed ID: 15691618

  • 1. Effects of circadian rhythms, posture, and medication on renin-aldosterone interrelations in essential hypertensives.
    Lamarre-Cliche M, de Champlain J, Lacourcière Y, Poirier L, Karas M, Larochelle P.
    Am J Hypertens; 2005 Jan; 18(1):56-64. PubMed ID: 15691618
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A multicenter, 14-week study of telmisartan and ramipril in patients with mild-to-moderate hypertension using ambulatory blood pressure monitoring.
    Lacourcière Y, Neutel JM, Davidai G, Koval S.
    Am J Hypertens; 2006 Jan; 19(1):104-12. PubMed ID: 16461201
    [Abstract] [Full Text] [Related]

  • 4. Effect of telmisartan vs. ramipril on 'dipping' status and blood pressure variability: pooled analysis of the PRISMA studies.
    Gosse P, Schumacher H.
    Hypertens Res; 2014 Feb; 37(2):151-7. PubMed ID: 24048485
    [Abstract] [Full Text] [Related]

  • 5. Antihypertensive efficacy of telmisartan vs ramipril over the 24-h dosing period, including the critical early morning hours: a pooled analysis of the PRISMA I and II randomized trials.
    Williams B, Lacourcière Y, Schumacher H, Gosse P, Neutel JM.
    J Hum Hypertens; 2009 Sep; 23(9):610-9. PubMed ID: 19225530
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of the renin-angiotensin-aldosterone system: is there room for dual blockade in the cardiorenal continuum?
    Volpe M, Danser AH, Menard J, Waeber B, Mueller DN, Maggioni AP, Ruilope LM.
    J Hypertens; 2012 Apr; 30(4):647-54. PubMed ID: 22278139
    [Abstract] [Full Text] [Related]

  • 7. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
    Miranda RD, Mion D, Rocha JC, Kohlmann O, Gomes MA, Saraiva JF, Amodeo C, Filho BL.
    Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
    [Abstract] [Full Text] [Related]

  • 8. [Aldosterone-to-renin ratio threshold for screening primary aldosteronism in Chinese hypertensive patients].
    Chen SX, Du YL, Zhang J, Gong YC, Hu YR, Chu SL, He QB, Song YY, Zhu DL.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Oct; 34(10):868-72. PubMed ID: 17217708
    [Abstract] [Full Text] [Related]

  • 9. Telmisartan improves insulin resistance in high renin nonmodulating salt-sensitive hypertensives.
    Sanchez RA, Masnatta LD, Pesiney C, Fischer P, Ramirez AJ.
    J Hypertens; 2008 Dec; 26(12):2393-8. PubMed ID: 19008718
    [Abstract] [Full Text] [Related]

  • 10. [Differences of blood plasma renin activity, angiotensin II and aldosterone levels in essential or secondary hypertension].
    Song AL, Zeng ZP, Tong AL, Lu L, Chen S, Li M, Fu CL, Wang YH, Sun ML.
    Zhonghua Nei Ke Za Zhi; 2012 Apr; 51(4):294-8. PubMed ID: 22781950
    [Abstract] [Full Text] [Related]

  • 11. Does aldosterone-to-renin ratio predict the antihypertensive effect of the aldosterone antagonist spironolactone?
    Mahmud A, Mahgoub M, Hall M, Feely J.
    Am J Hypertens; 2005 Dec; 18(12 Pt 1):1631-5. PubMed ID: 16364838
    [Abstract] [Full Text] [Related]

  • 12. A comparison of the efficacy and duration of action of telmisartan, amlodipine and ramipril in patients with confirmed ambulatory hypertension.
    Poirier L, de Champlain J, Larochelle P, Lamarre-Cliche M, Lacourcière Y.
    Blood Press Monit; 2004 Oct; 9(5):231-6. PubMed ID: 15472494
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Short-term dietary salt supplementation blunts telmisartan induced increases in plasma renin activity in hypertensive patients with type 2 diabetes mellitus.
    Chen AX, Jerums G, Baqar S, Lambert E, Somarajah G, Thomas G, O'Callaghan C, MacIsaac RJ, Ekinci EI.
    Clin Sci (Lond); 2015 Sep; 129(5):415-22. PubMed ID: 25849646
    [Abstract] [Full Text] [Related]

  • 15. Effect of switching from amlodipine to combination therapy with telmisartan and low-dose hydrochlorothiazide.
    Ando K, Isshiki M, Takahashi K, ONgoing Evaluation of depressor effect And Safety of combination therapy with Telmisartan and low-dose hydrochlorothiazide (ONEAST) Study Group.
    Hypertens Res; 2009 Sep; 32(9):748-52. PubMed ID: 19590506
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Evaluation of fixed dose combination (FDC) of telmisartan+ramipril usage in patients with micro-albuminuria and persistent hypertension: A TRIUMPH study.
    Sharma A, Baliga V, TRIUMPH Study Group.
    J Indian Med Assoc; 2008 Mar; 106(3):191-4, 196. PubMed ID: 18712142
    [Abstract] [Full Text] [Related]

  • 19. Effect of telmisartan-amlodipine combination at different doses on urinary albumin excretion in hypertensive diabetic patients with microalbuminuria.
    Fogari R, Derosa G, Zoppi A, Preti P, Lazzari P, Destro M, Fogari E, Rinaldi A, Mugellini A.
    Am J Hypertens; 2007 Apr; 20(4):417-22. PubMed ID: 17386350
    [Abstract] [Full Text] [Related]

  • 20. The renin-angiotensin receptor blocker azilsartan medoxomil compared with the angiotensin-converting enzyme inhibitor ramipril in clinical trials versus routine practice: insights from the prospective EARLY registry.
    Bramlage P, Schmieder RE, Gitt AK, Baumgart P, Mahfoud F, Buhck H, Ouarrak T, Ehmen M, Potthoff SA, EARLY Registry Group.
    Trials; 2015 Dec 19; 16():581. PubMed ID: 26686682
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.